P. Hillemanns et al., Photodetection of cervical intraepithelial neoplasia using 5-aminolevulinic acid-induced porphyrin fluorescence, CANCER, 88(10), 2000, pp. 2275-2282
BACKGROUND. Screening for cervical carcinoma and its precursors is based on
cervical cytology and diagnostic colposcopy. Despite the decrease in the i
ncidence of cervical carcinoma in countries with a good screening program,
this rate of decline is leveling off. Known problems are false-negative rat
es of cytology and low specificity of colposcopy. This clinical study exami
ned the diagnostic potential of porphyrin fluorescence in patients with cer
vical intraepithelial neoplasia Grade 1-3 (CIN 1-3).
METHODS. Sixty-eight women attending our colposcopy clinic underwent a gyne
cologic examination, including cytology, human papillomavirus (HPV) testing
, and colposcopy, They received 10 mt 0.5% or 1.0% 5-aminolevulinic acid (5
-ALA) topically. After 30-360 minutes, real-time image analysis was perform
ed, and spectra were obtained from 685 sites.
RESULTS. Due to rapid photobleaching, 0.5% 5-ALA proved ineffective for flu
orescence assessment. Using 1% 5-ALA, the authors found that fluorescence i
ntensities correlated with incubation time; however, fluorescence contrast
showed a maximum at 60-90 minutes (ratio 11:1). HPV DNA positive lesions sh
owed significantly higher fluorescence. Fluorescence imaging after 60-90 mi
nutes achieved similar sensitivity and specificity compared with colposcopy
in detecting CIN with 94% and 51% Versus 95% and 50%, respectively. Howeve
r, the specificity was markedly improved by fluorescence spectroscopy, achi
eving 75%. The evaluation of spectral measurements revealed significantly h
igher values for CIN compared with normal tissue and for CIN 2/3 compared w
ith CIN 1 (P < 0.001).
CONCLUSIONS. Using a time interval of 60-90 minutes after topical applicati
on of 1% 5-ALA, the authors observed specific porphyrin fluorescence of GIN
. Fluorescence spectroscopy promises to become a valuable tool for the diag
nosis of GIN. Cancer 2000;88:2275-82, (C) 2000 American Cancer Society.